glp 1 pregnancy category GLP-1 use during early may not increase risk of major adverse outcomes GLP-1 receptor agonists | How

Entire contents copyright 2025 by InsuranceNewsNet.com Inc

(2024, February 11)

Yes, we need to pay attention to the [gastrointestinal] adverse events, but that is not the whole story. A great opportunity for future research Other key questions about GLP-1s that need to be answered are when or if it is appropriate to stop them, and why there is such wide variation in how patients respond to them

[39] It completed phase III trials globally in 2021

This is important for healthcare providers and patients to know their treatment plan

References Glucagon-like peptide-1 (GLP-1) agonists are a class of medications utilized to treat type 2 diabetes mellitus (T2DM) and obesity